Douglas K. Tadaki

3.3k total citations · 1 hit paper
56 papers, 2.6k citations indexed

About

Douglas K. Tadaki is a scholar working on Immunology, Surgery and Transplantation. According to data from OpenAlex, Douglas K. Tadaki has authored 56 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 16 papers in Surgery and 15 papers in Transplantation. Recurrent topics in Douglas K. Tadaki's work include T-cell and B-cell Immunology (17 papers), Immunotherapy and Immune Responses (12 papers) and Renal Transplantation Outcomes and Treatments (11 papers). Douglas K. Tadaki is often cited by papers focused on T-cell and B-cell Immunology (17 papers), Immunotherapy and Immune Responses (12 papers) and Renal Transplantation Outcomes and Treatments (11 papers). Douglas K. Tadaki collaborates with scholars based in United States, Japan and Switzerland. Douglas K. Tadaki's co-authors include Allan D. Kirk, David M. Harlan, Eric A. Elster, Robert L. Kampen, S. John Swanson, Justin D. Berning, Linda C. Burkly, Noelle B. Patterson, He Xu and Salil K. Niyogi and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Douglas K. Tadaki

55 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

1999 666 citations Allan D. Kirk, Linda C. Burkly et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas K. Tadaki United States	24	1.0k	805	800	428	311	56	2.6k
Willem Weimar Netherlands	35	1.1k 1.0×	1.2k 1.5×	1.2k 1.5×	553 1.3×	475 1.5×	108	3.6k
W. Weimar Netherlands	28	927 0.9×	852 1.1×	924 1.2×	389 0.9×	400 1.3×	137	2.7k
Federica Casiraghi Italy	30	911 0.9×	633 0.8×	1.3k 1.6×	757 1.8×	198 0.6×	70	3.5k
Jean Paul Soulillou France	23	690 0.7×	765 1.0×	640 0.8×	326 0.8×	277 0.9×	64	2.1k
P Coates Australia	32	808 0.8×	409 0.5×	922 1.2×	605 1.4×	213 0.7×	96	2.7k
T. Mohanakumar United States	31	815 0.8×	716 0.9×	1.5k 1.9×	435 1.0×	261 0.8×	106	2.7k
Alan Ting United Kingdom	22	996 1.0×	593 0.7×	466 0.6×	248 0.6×	205 0.7×	40	2.1k
Sylvie Ferrari‐Lacraz Switzerland	20	1.0k 1.0×	320 0.4×	338 0.4×	352 0.8×	310 1.0×	60	1.9k
Debra A. Hullett United States	28	376 0.4×	437 0.5×	873 1.1×	530 1.2×	120 0.4×	89	2.0k
Eeva von Willebrand Finland	26	542 0.5×	922 1.1×	702 0.9×	239 0.6×	345 1.1×	93	2.1k

Countries citing papers authored by Douglas K. Tadaki

Since Specialization

Citations

This map shows the geographic impact of Douglas K. Tadaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas K. Tadaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas K. Tadaki more than expected).

Fields of papers citing papers by Douglas K. Tadaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas K. Tadaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas K. Tadaki. The network helps show where Douglas K. Tadaki may publish in the future.

Co-authorship network of co-authors of Douglas K. Tadaki

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas K. Tadaki. A scholar is included among the top collaborators of Douglas K. Tadaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas K. Tadaki. Douglas K. Tadaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paredes, Roger, et al.. (2017). Generation of complement molecular complex C5b-9 (C5b-9) in response to poly-traumatic hemorrhagic shock and evaluation of C5 cleavage inhibitors in non-human primates. International Immunopharmacology. 54. 221–225. 9 indexed citations

Sheppard, Forest R., Antoni R. Macko, Jacob Glaser, et al.. (2017). Nonhuman Primate (Rhesus Macaque) Models of Severe Pressure-Targeted Hemorrhagic and Polytraumatic Hemorrhagic Shock. Shock. 49(2). 174–186. 20 indexed citations

Sheppard, Forest R., et al.. (2015). Development of a Nonhuman Primate (Rhesus Macaque) Model of Uncontrolled Traumatic Liver Hemorrhage. Shock. 44(Supplement 1). 114–122. 15 indexed citations

Brown, Trevor S., Jason Hawksworth, Forest R. Sheppard, Douglas K. Tadaki, & Eric A. Elster. (2011). Inflammatory Response Is Associated with Critical Colonization in Combat Wounds. Surgical Infections. 12(5). 351–357. 28 indexed citations

Sheppard, Forest R., Korboi N. Evans, John Christopher Graybill, et al.. (2011). Incidence of Pulmonary Embolus in Combat Casualties With Extremity Amputations and Fractures. The Journal of Trauma: Injury, Infection, and Critical Care. 71(3). 607–613. 33 indexed citations

Elster, Eric A., Jason Hawksworth, David B. Leeser, et al.. (2010). Probabilistic (Bayesian) Modeling of Gene Expression in Transplant Glomerulopathy. Journal of Molecular Diagnostics. 12(5). 653–663. 10 indexed citations

Amare, Mihret F., et al.. (2010). Comparative analysis of angiogenic gene expression in normal and impaired wound healing in diabetic mice: effects of extracorporeal shock wave therapy. Angiogenesis. 13(4). 293–304. 44 indexed citations

Davis, Thomas A., Alexander Stojadinovic, Khairul Anam, et al.. (2008). Extracorporeal shock wave therapy suppresses the early proinflammatory immune response to a severe cutaneous burn injury*. International Wound Journal. 6(1). 11–21. 115 indexed citations

Davis, Thomas A., Mihret F. Amare, Shruti Naik, Alexander L. Kovalchuk, & Douglas K. Tadaki. (2007). Differential cutaneous wound healing in thermally injured MRL/MPJ mice. Wound Repair and Regeneration. 15(4). 577–588. 25 indexed citations

10.

Xu, He, Sean P. Montgomery, Douglas K. Tadaki, et al.. (2003). Studies Investigating Pretransplant Donor-Specific Blood Transfusion, Rapamycin, and the CD154-Specific Antibody IDEC-131 in a Nonhuman Primate Model of Skin Allotransplantation. The Journal of Immunology. 170(5). 2776–2782. 54 indexed citations

11.

Montgomery, Sean P., Steven Mog, He Xu, et al.. (2002). Efficacy and Toxicity of a Protocol Using Sirolimus, Tacrolimus and Daclizumab in a Nonhuman Primate Renal Allotransplant Model. American Journal of Transplantation. 2(4). 381–385. 28 indexed citations

12.

Xu, He, Douglas K. Tadaki, Eric A. Elster, et al.. (2002). Humanized anti-CD154 antibody therapy for the treatment of allograft rejection in nonhuman primates. Transplantation. 74(7). 940–943. 29 indexed citations

13.

Elster, Eric A., He Xu, Douglas K. Tadaki, et al.. (2001). Primate skin allotransplantation with anti-CD154 monotherapy. Transplantation Proceedings. 33(1-2). 675–676. 15 indexed citations

14.

Kirk, Allan D., Douglas K. Tadaki, Abbie Celniker, et al.. (2001). INDUCTION THERAPY WITH MONOCLONAL ANTIBODIES SPECIFIC FOR CD80 AND CD86 DELAYS THE ONSET OF ACUTE RENAL ALLOGRAFT REJECTION IN NON-HUMAN PRIMATES1. Transplantation. 72(3). 377–384. 108 indexed citations

15.

Elster, Eric A., He Xu, Douglas K. Tadaki, et al.. (2001). TREATMENT WITH THE HUMANIZED CD154-SPECIFIC MONOCLONAL ANTIBODY, hu5C8, PREVENTS ACUTE REJECTION OF PRIMARY SKIN ALLOGRAFTS IN NONHUMAN PRIMATES1. Transplantation. 72(9). 1473–1478. 75 indexed citations

16.

Kirk, Allan D., Douglas K. Tadaki, He Xu, et al.. (2000). PRIMATE ALLOTRANSPLANTATION USING COSTIMULATION BLOCKADE.. Transplantation. 69(Supplement). S414–S414. 3 indexed citations

17.

Murray, M B, et al.. (1998). Structure-function analysis of a conserved aromatic cluster in the N- terminal domain of human epidermal growth factor. Protein Engineering Design and Selection. 11(11). 1041–1050. 7 indexed citations

18.

Tadaki, Douglas K., et al.. (1998). COSTIMULATORY PATHWAYS ARE ACTIVE IN XENOGENEIC IMMUNE RESPONSES.. Transplantation. 65(Supplement). 87–87. 1 indexed citations

19.

French, Anthony R., Douglas K. Tadaki, Salil K. Niyogi, & Douglas A. Lauffenburger. (1995). Intracellular Trafficking of Epidermal Growth Factor Family Ligands Is Directly Influenced by the pH Sensitivity of the Receptor/Ligand Interaction. Journal of Biological Chemistry. 270(9). 4334–4340. 185 indexed citations

20.

Niyogi, Salil K., et al.. (1992). Evaluation of the role of electrostatic residues in human epidermal growth factor by site‐directed mutagenesis and chemical modification. Journal of Cellular Biochemistry. 50(1). 35–42. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact